Search Results 1771-1780 of 21395 for anti-TNF drugs

1. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... drug (venetoclax and gilteritinib). Subject cannot have received treatment with anti-leukemia therapy, including chemotherapy, radiotherapy or any ...

2. Safety and Efficacy of ALLO-715 and ALLO-647 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) - Mayo Clinic

   - Prior treatment with anti-BCMA therapy, any gene therapy, any genetically modified cell therapy, or adoptive T cell therapy - History of HIV infection or ...

3. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Concurrent anti-cancer therapy (chemotherapy, radiation therapy, surgery ...

4. Early Feasibility of Endoscopic Gastric Mucosal Ablation (GMA) as a Primary Obesity Therapy - Mayo Clinic

   By condition, treatment or drug name ... Use of glucose-lowering drugs for diabetes mellitus treatment ... Obligate use of anti-inflammatory drugs that ...

5. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Use of any standard or experimental anti-cancer therapy within 2 weeks prior ...

6. Hyoscyamine, Methenamine, Methylene Blue, Phenyl Salicylate, And Sodium Phosphate (Oral Route) Description and Brand Names - Mayo Clinic

   Hyoscyamine is an antispasmodic drug, which relieves muscle cramps or spasms. Methenamine and methylene blue are antiseptic drugs, which help clear a ...

7. Raltegravir (Oral Route) Proper Use - Mayo Clinic

   Dosing · For treatment of HIV infection (patient already had HIV treatment):. For oral dosage form (Isentress® film-coated tablets):. Adults—400 milligrams (mg) ...

8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   It is the responsibility of the investigator to verify the adequacy of previous anti-TB treatment and provide appropriate documentation. Newly identified ...

9. Meloxicam (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

10. Clinical Trials - Division of Infectious Diseases

    Drugs & Supplements A-Z · Health Books · Healthy ... The purpose of this study is to measure changes of the anti- A/H1N1, anti ... treatment guidelines for the ...